Open AccessStable Caloric Intake and Continued Virologic Suppression for Human Immunodeficiency Virus-Positive Antiretroviral Treatment Experienced Women After Switching to Fixed-Dose Combination of Emtricitabine, Tenofovir and Rilpivirine
Author(s) -
Prema Menezes,
Katie R. Mollan,
Erin Hoffman,
Parker Xie,
Jennifer Wills,
Cheryl Marcus,
John Rublein,
Michael G. Hudgens,
Joseph J. Eron
Publication year - 2015
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofv133.624
Subject(s) - rilpivirine , emtricitabine , medicine , tenofovir , human immunodeficiency virus (hiv) , virology , antiretroviral therapy , antiretroviral treatment , caloric intake , viral load , pharmacology , body weight